This gene is one of the 45 gene signatures for metastatic predictor in triple-negative breast cancer (TNBC) whereby the high expression of POTED was associated with poor prognosis (Kuo et al., 2012). This evidence concerns the gene POTED and triple-negative breast carcinoma.